Four grid table. by Xiaoling Zhong (181270)

Subjects:

Flowchart depicting the selection of the study population. by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration at the PT level (age < 18). by Xiaoling Zhong (181270)

Subjects:

Basic information and patient characteristics according to the report. by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration at the preferred term level in the FAERS database. by Xiaoling Zhong (181270)

Subjects:

Four major algorithms used for signal detection. by Xiaoling Zhong (181270)

Subjects:

Time to onset of AEs in male and female patients receiving finasteride therapy. by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration at the SOC level. by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration at the SOC level by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration in female at the PT level. by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration in male at the PT level. by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration at the PT level (age = 18-65). by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration at the PT level (age>=65). by Xiaoling Zhong (181270)

Subjects:

Clinical characteristics of reports with finasteride as the primary suspected drug from the FAERS database. by Xiaoling Zhong (181270)

Subjects:

Sex-differentiated risk signal volcano plot for finasteride. by Xiaoling Zhong (181270)

Subjects:

Number of adverse reaction case reports of finasteride administration at the PT level. by Xiaoling Zhong (181270)

Subjects:

WT data of set A398E/V and set M1425V/I pooled for better comparison. by Yousra El Ghaleb (22075892)

Fig 4 - by Leena Inkilä (20614460)

Distinct effects on calcium channel activation of <i>CACNA1I</i> disease-associated amino acid substitutions A398E/V and M1425V/I. by Yousra El Ghaleb (22075892)

Table 1_Altered Th17/Treg balance and therapeutic targeting of RORγ in primary focal hyperhidrosis.docx by Min Lin (17652)

“…Elevated IL-17 and IL-6 and reduced IL-10 and TGF-β1 levels were observed in PFH serum. Sweat glands showed increased RORγt and decreased FOXP3 expression. …”